MedTrace Logo

Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan

NCT05449717 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2025-04-24

No results posted yet for this study

Summary

This study aims to describe the burden of Post-Kala-Azar Dermal Leishmaniasis and visceral leishmaniasis relapse in a cohort of patients discharged after successful treatment of primary visceral leishmaniasis.

Conditions

  • Leishmaniasis
  • Leishmaniasis, Visceral
  • Post-kala-azar Dermal Leishmaniasis

Sponsors & Collaborators

  • European and Developing Countries Clinical Trials Partnership (EDCTP)

    collaborator OTHER_GOV

  • Drugs for Neglected Diseases

    collaborator OTHER

  • Medecins Sans Frontieres, Netherlands

    collaborator OTHER

  • Epicentre

    lead OTHER

Principal Investigators

  • Rebecca M Coulborn, MPH · Epicentre

  • Margriet den Boer, MD · Medecins Sans Frontieres, Netherlands

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-31
Primary Completion
2025-04-11
Completion
2025-04-11

Countries

  • South Sudan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05449717 on ClinicalTrials.gov